The Department of Defense (DoD) offers this Lung Cancer Clinical Exploration Award to fund early-phase, proof-of-principle clinical trials and correlative studies. This grant supports innovative, hypothesis-based interventions and research avenues designed to overcome clinical barriers and significantly impact lung cancer management. It targets novel therapies or new applications of existing treatments, with outcomes providing scientific rationale for future efficacy trials. The award funds Phase 0, Phase I, or pilot Phase II clinical trials for drugs, devices, or other early clinical testing. Collaboration with investigators at Military Medical Treatment Facilities, Military labs, and VA Medical Centers is strongly encouraged.
Opportunity ID: 235260
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-LCRP-CEA |
| Funding Opportunity Title: | DoD Lung Cancer Clinical Exploration Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 21, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 16, 2013 |
| Current Closing Date for Applications: | Oct 16, 2013 |
| Archive Date: | Nov 15, 2013 |
| Estimated Total Program Funding: | $720,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The LCRP Clinical Exploration Award mechanism is being offered for the first time in FY13. The intent of the LCRP Clinical Exploration Award (CEA) is to support early-phase, proof-of-principle clinical trials and correlative studies to investigate hypothesis-based, innovative interventions and/or avenues of research that have the potential to resolve current clinical barriers and result in a profound impact on the clinical management of lung cancer. While therapeutic approaches proposed for testing through the CEA must represent novel, hypothesisbased, outside-the-box approaches for treating lung cancer, they may include therapies already in clinical use, or undergoing clinical testing, for other diseases, provided that the proposed use for lung cancer would lead to a major advancement for treating the disease. It is anticipated that outcomes from studies funded by this award will provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform lung cancer clinical care. Submissions from and partnerships with investigators at Military Medical Treatment Facilities, Military labs, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories are encouraged. Clinical Trials: The CEA will support clinical trials encompassing Phase 0, Phase I, or pilot Phase II for drug or drug combinations, Class II or III devices, or other types of trials that conduct early clinical testing of innovative approaches for lung cancer. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
301-682-5507 Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 235260 Full Announcement-1 -> lcrp fy13 cea pa_gg.pdf
Folder 235260 Full Announcement-1 -> fy13 ind-ide documentation fillable form.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00178433 | May 21, 2013 | Oct 16, 2013 | View |
Package 1
Mandatory forms
235260 RR_SF424_1_2-1.2.pdf
235260 PerformanceSite_1_4-1.4.pdf
235260 RR_Budget-1.1.pdf
235260 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
235260 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
